SEC Form D · filed May 22, 2020
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Mijia (Bob) E. Wu · EMERYVILLE, CADirectorAndrew M. Jones · EMERYVILLE, CAExecSwan E. Sit · EMERYVILLE, CADirectorJustin M. Hall · EMERYVILLE, CAExecPaul E. Freiman · EMERYVILLE, CADirectorXiaopei (Ray) Wang · EMERYVILLE, CADirectorYenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorXinzhou (Paul) E. Li · EMERYVILLE, CADirectorSean Stiefel · Redondo Beach, CAExecBrook Katzen · Chilmark, MADirectorWilliam Burns · McKinney, TXExecSamuel Schreiber · Chilmark, MADirectorCato Partners Management, LLC · New York, NYDirectorCato Partners GP, LLC · New York, NYDirectorJp A. Paquin · New York, NYDirectorMatt Forti · Highland Park, ILDirectorDavid Irwin · Bellevue, WADirectorSteven M. Diedrich · Waco, TXDirectorBrian Moreland · Bronx, NYDirectorJerry L. Whitmire · Tempe, AZDirectorvan Biema Value Partners, LLC · New York, NYDirectorvan Biema & Company, LLC · New York, NYExecJeff Siegel · Huntsville, UTExecStephen Dalby · Lehi, UTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗